IDR 16.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 13.23 Billion | -279.51 Million | 5.27 Billion | 2.4 Billion | 4.01 Billion | -19.81 Billion |
Net Income | 6.33 Billion | -279.51 Million | -4.93 Billion | -6.52 Billion | -392.32 Million | 2.83 Billion |
Depreciation & Amortization | 518.45 Million | 462.6 Million | 472.43 Million | 1.38 Billion | 1.36 Billion | 1.37 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 6.37 Billion | -462.6 Million | 9.73 Billion | 7.54 Billion | 3.04 Billion | -2.83 Billion |
Investing Cash Flow | -23.62 Million | -1.38 Billion | 76.26 Billion | -3.37 Billion | 24.98 Billion | -25.03 Billion |
Investments in PPE | -23.62 Million | -1.38 Billion | -2.05 Billion | -3.37 Billion | -21.31 Million | -73.94 Billion |
Acquisitions | - | - | 3.32 Billion | - | 2.45 Million | -1.09 Billion |
Investment purchases | - | - | -3.32 Billion | - | -2.45 Million | - |
Sales/Maturities of investments | - | - | 75 Billion | - | 25 Billion | 50 Billion |
Other Investing Activities | -19.85 Million | -23 Million | 3.32 Billion | -3.35 Billion | 2.45 Million | -10.15 Billion |
Financing Cash Flow | -15.15 Billion | -25 Billion | -5.68 Billion | -8.33 Billion | -24.99 Billion | 47.77 Billion |
Debt repayment | -15.15 Billion | -25 Billion | -5.68 Billion | -8.33 Billion | -24.99 Billion | -52.65 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | 1.43 Million | 411.13 Million |
Other Financing Activities | - | -25 Billion | -5.68 Billion | -8.33 Billion | -24.99 Billion | 100.02 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 73.37 Billion | 76.77 Billion | 928.52 Million | 10.22 Billion | 6.22 Billion | 3.3 Billion |
Cash at end of period | 71.43 Billion | 73.37 Billion | 76.77 Billion | 928.52 Million | 10.22 Billion | 6.22 Billion |
Capital Expenditure | -23.62 Million | -1.38 Billion | -2.05 Billion | -3.37 Billion | -21.31 Million | -73.94 Billion |
Effect of forex changes on cash | - | 23.25 Billion | - | - | - | - |
Net cash flow / Change in cash | -1.93 Billion | -3.4 Billion | 75.84 Billion | -9.3 Billion | 4 Billion | 2.92 Billion |
Free Cash Flow | 13.21 Billion | -1.66 Billion | 3.21 Billion | -969.25 Million | 3.99 Billion | -93.75 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.09 Billion | 1.9 Billion | 6.33 Billion | 3.29 Billion | 1.32 Billion | 1.12 Billion |
Depreciation & Amortization | 124.99 Million | 123.8 Million | 518.45 Million | 127.76 Million | 196.77 Million | 62.42 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -4.49 Billion | -2.16 Billion | 6.37 Billion | -4.27 Billion | 976.72 Million | 4.08 Billion |
Investing Cash Flow | -97.12 Million | 10.36 Million | -23.62 Million | -866.07 Thousand | -4.18 Million | -18.57 Million |
Investments in PPE | -71.57 Million | - | -23.62 Million | 411.92 Thousand | -4.18 Million | -19.85 Million |
Acquisitions | -10.36 Million | 10.36 Million | - | -1.27 Million | - | 1.27 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -25.54 Million | 10.36 Million | -19.85 Million | 2.91 Million | -4.18 Million | -18.57 Million |
Financing Cash Flow | - | - | -15.15 Billion | - | -2.61 Billion | -6.28 Billion |
Debt repayment | - | - | -15.15 Billion | - | -2.61 Billion | -6.28 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | -2.61 Billion | -6.28 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 71.17 Billion | 71.43 Billion | 73.37 Billion | 72.28 Billion | 72.4 Billion | 73.43 Billion |
Cash at end of period | 68.55 Billion | 71.17 Billion | 71.43 Billion | 71.43 Billion | 72.28 Billion | 72.4 Billion |
Capital Expenditure | -71.57 Million | - | -23.62 Million | 411.92 Thousand | -4.18 Million | -19.85 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -2.62 Billion | -254.48 Million | -1.93 Billion | -848.51 Million | -125.51 Million | -1.02 Billion |
Free Cash Flow | -2.59 Billion | -264.85 Million | 13.21 Billion | -847.23 Million | 2.49 Billion | 5.25 Billion |
3948
CLEMO
STERV
BODALCHEM
1272
OILS